APRIL SMITH: Open Payments
NPI 1871899690 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$395 in 11 payments from 6 companies in 2025. Trend: 2023 $632 · 2024 $298 · 2025 $395
Food & beverage: $395
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $142 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $140 |
| Novo Nordisk Inc | 3 | $62 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $21 |
| Lilly USA, LLC | 1 | $16 |
| Abbott Laboratories | 1 | $14 |
Products named: CAPLYTA, AIRSUPRA, FARXIGA, XIFAXAN, Ozempic, MOUNJARO, FREESTYLE LIBRE 3.
Industry payments across FL — which companies pay providers there.
